Back
OncoCyte Stock Price Chart
Sponsored
OCX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
OCX
OncoCyte
Last Price:
2.70
Seasonality Move:
42.9%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight selling pressure.
OncoCyte Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.71 | Buy |
20-day SMA: | 2.86 | Sell |
50-day SMA: | 2.97 | Sell |
200-day SMA: | 2.94 | Sell |
8-day EMA: | 2.72 | Sell |
20-day EMA: | 2.82 | Sell |
50-day EMA: | 2.93 | Sell |
200-day EMA: | 3.2 | Sell |
OncoCyte Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 41.8 | Sell |
Chaikin Money Flow: | -8651 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.73 - 3.07) | Sell |
Bollinger Bands (100): | (2.89 - 3.21) | Sell |
OncoCyte Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OncoCyte Stock
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.71 while OCX 8-day simple moving average is 2.71, which is a Buy signal.
- The stock price of OCX is 2.71 while OncoCyte 20-day SMA is 2.86, which makes it a Sell.
- OncoCyte 50-day simple moving average is 2.97 while OCX share price is 2.71, making it a Sell technically.
- OCX stock price is 2.71 and OncoCyte 200-day simple moving average is 2.94, creating a Sell signal.
OCX Technical Analysis vs Fundamental Analysis
OncoCyte Stock Info
Market Cap:
45.62M
Price in USD:
2.71
Share Volume:
45.27K
OncoCyte 52-Week Range
52-Week High:
4.31
52-Week Low:
2.29
Sell
45
OncoCyte (OCX)
is a Sell
OncoCyte Share Price Forecast
-
What is the OncoCyte stock price today?
The OncoCyte stock price is 2.71 USD today. -
Will OCX stock go up or go down?
OncoCyte> share price is forecast to RISE/FALL based on technical indicators -
Is OncoCyte overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, OncoCyte is overvalued.
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.71 while OCX 8-day exponential moving average is 2.72, which is a Sell signal.
- The stock price of OCX is 2.71 while OncoCyte 20-day EMA is 2.82, which makes it a Sell.
- OncoCyte 50-day exponential moving average is 2.93 while OCX share price is 2.71, making it a Sell technically.
- OCX stock price is 2.71 and OncoCyte 200-day simple moving average is 3.20, creating a Sell signal.
Fundamental Analysis of OncoCyte
Is OncoCyte a good investment?
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Technical Analysis of OncoCyte
Should I short OncoCyte stock?
- OCX Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting OncoCyte is a Sell
- OncoCyte Relative Strength Index (RSI) is 41.8, which suggest OncoCyte is oversold
- The Bollinger Bands (25) for OncoCyte is (2.73 - 3.07), which suggest OncoCyte is a Sell
- The Bollinger Bands (100) for OncoCyte is (2.89 - 3.21), which suggest OncoCyte is a Sell
* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.